ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Oral topotecan is well tolerated as second-line therapy for ovarian cancer
Evidence-based Oncology
◽
10.1054/ebon.2002.0026
◽
2002
◽
Vol 3
(3)
◽
pp. 120-122
Author(s):
Howard Hochster
Keyword(s):
Ovarian Cancer
◽
Second Line
◽
Second Line Therapy
◽
Line Therapy
◽
Oral Topotecan
Download Full-text
Related Documents
Cited By
References
Faculty of 1000 evaluation for Phase I dose-escalation study and population pharmacokinetic analysis of fixed dose rate gemcitabine plus carboplatin as second-line therapy in patients with ovarian cancer.
F1000 - Post-publication peer review of the biomedical literature
◽
10.3410/f.718016158.793478648
◽
2013
◽
Author(s):
Steve Plaxe
◽
Kristy Ward
Keyword(s):
Ovarian Cancer
◽
Population Pharmacokinetic Analysis
◽
Fixed Dose
◽
Pharmacokinetic Analysis
◽
Population Pharmacokinetic
◽
Second Line
◽
Second Line Therapy
◽
Dose Escalation Study
◽
Line Therapy
◽
Fixed Dose Rate
Download Full-text
Hexamethylmelamine as second-line therapy in platin-resistant ovarian cancer
Gynecologic Oncology
◽
10.1016/0090-8258(92)90127-5
◽
1992
◽
Vol 47
(3)
◽
pp. 282-286
◽
Cited By ~ 50
Author(s):
Ignace Vergote
◽
Anna Himmelmann
◽
Bo Frankendal
◽
Marit Scheistrøen
◽
Kerstin Vlachos
◽
...
Keyword(s):
Ovarian Cancer
◽
Second Line
◽
Second Line Therapy
◽
Line Therapy
Download Full-text
SECOND-LINE THERAPY WITH TOPOTECAN AND PEGYLATED LIPOSOMAL DOXORUBICIN VS. TOPOTECAN ALONE IN PATIENTS WITH RECURRENT OVARIAN CANCER
International Journal of Gynecological Cancer
◽
10.1136/ijgc-00009577-200303001-00188
◽
2003
◽
Vol 13
(Suppl 1)
◽
pp. 53.4-53
◽
Cited By ~ 1
Author(s):
P. L. Cherchi
◽
G. Capobianco
◽
F. Fattorini
◽
A. M. Canetto
◽
L. Milia
◽
...
Keyword(s):
Ovarian Cancer
◽
Liposomal Doxorubicin
◽
Pegylated Liposomal Doxorubicin
◽
Recurrent Ovarian Cancer
◽
Second Line
◽
Second Line Therapy
◽
Line Therapy
Download Full-text
EFFECTS OF INTRAPERITONEAL CHEMOTHERAPY AS A SECOND LINE THERAPY, FOR PATIENTS WITH OVARIAN CANCER
International Journal of Gynecological Cancer
◽
10.1136/ijgc-00009577-200303001-00046
◽
2003
◽
Vol 13
(Suppl 1)
◽
pp. 14.1-14
Author(s):
T. Milczek
◽
J. Emerich
◽
D. Klasa-Mazurkiewicz
Keyword(s):
Ovarian Cancer
◽
Intraperitoneal Chemotherapy
◽
Second Line
◽
Second Line Therapy
◽
Line Therapy
Download Full-text
Paclitaxel vs Epidoxorubicin plus Paclitaxel as Second-Line Therapy for Platinum-Refractory and -Resistant Ovarian Cancer
Gynecologic Oncology
◽
10.1006/gyno.1998.5237
◽
1999
◽
Vol 72
(1)
◽
pp. 60-64
◽
Cited By ~ 49
Author(s):
Giorgio Bolis
◽
Fabio Parazzini
◽
Giovanna Scarfone
◽
Antonella Villa
◽
Mariangela Amoroso
◽
...
Keyword(s):
Ovarian Cancer
◽
Second Line
◽
Second Line Therapy
◽
Line Therapy
◽
Platinum Refractory
Download Full-text
Phase II Clinical Study on the GEMOX Regimen as Second-line Therapy for Advanced Ovarian Cancer
Asian Pacific Journal of Cancer Prevention
◽
10.7314/apjcp.2013.14.6.3949
◽
2013
◽
Vol 14
(6)
◽
pp. 3949-3953
◽
Cited By ~ 4
Author(s):
Shao-Fei Yuan
◽
Lian-Ping Zhang
◽
Lin-Jia Zhu
◽
Wen-Jun Chen
◽
Wei-E Zheng
◽
...
Keyword(s):
Ovarian Cancer
◽
Clinical Study
◽
Phase Ii
◽
Advanced Ovarian Cancer
◽
Second Line
◽
Second Line Therapy
◽
Line Therapy
◽
Phase Ii Clinical Study
Download Full-text
Retrospective Analysis of Carboplatin and Paclitaxel as Initial Second-Line Therapy for Recurrent Epithelial Ovarian Carcinoma: Application Toward a Dynamic Disease State Model of Ovarian Cancer
Journal of Clinical Oncology
◽
10.1200/jco.20.5.1238
◽
2002
◽
Vol 20
(5)
◽
pp. 1238-1247
◽
Cited By ~ 54
Author(s):
D. S. Dizon
Keyword(s):
Ovarian Cancer
◽
Ovarian Carcinoma
◽
Retrospective Analysis
◽
Epithelial Ovarian Carcinoma
◽
Disease State
◽
State Model
◽
Second Line
◽
Second Line Therapy
◽
Line Therapy
Download Full-text
Second-Line Therapy for Potentially Platinum-Sensitive Recurrent Ovarian Cancer: What Is Optimal Treatment?
Gynecologic Oncology
◽
10.1006/gyno.2001.6162
◽
2001
◽
Vol 81
(1)
◽
pp. 1-2
◽
Cited By ~ 5
Author(s):
Maurie Markman
Keyword(s):
Ovarian Cancer
◽
Recurrent Ovarian Cancer
◽
Optimal Treatment
◽
Second Line
◽
Second Line Therapy
◽
Platinum Sensitive
◽
Line Therapy
Download Full-text
Cisplatin and Doxorubicin as Second-Line Therapy in Ovarian Cancer
InPharma
◽
10.1007/bf03315737
◽
1984
◽
Vol 447
(1)
◽
pp. 9-9
Keyword(s):
Ovarian Cancer
◽
Second Line
◽
Second Line Therapy
◽
Line Therapy
Download Full-text
A phase II study of sabarubicin (MEN-10755) as second line therapy in patients with locally advanced or metastatic platinum/taxane resistant ovarian cancer
Investigational New Drugs
◽
10.1023/b:drug.0000047110.36382.45
◽
2005
◽
Vol 23
(1)
◽
pp. 85-89
◽
Cited By ~ 13
Author(s):
Francesco Caponigro
◽
Pax Willemse
◽
Roberto Sorio
◽
Anne Floquet
◽
Simon van Belle
◽
...
Keyword(s):
Ovarian Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Locally Advanced
◽
Second Line
◽
Second Line Therapy
◽
Line Therapy
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close